← Back to Search

Text Messaging Program for Depression (iDOVE2 Trial)

N/A
Recruiting
Led By Megan L Ranney, MD MPH
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months before enrollment and 12 months after enrollment
Awards & highlights

iDOVE2 Trial Summary

This trial is testing whether a text-message based depression prevention program can help reduce peer violence and depressive symptoms among at-risk youth.

Who is the study for?
This trial is for English-speaking adolescents who have experienced physical violence in the past year and are showing mild-to-moderate depressive symptoms. They must be getting routine care in an emergency department, have a parent or guardian present to consent, and own a cell phone that can send texts.Check my eligibility
What is being tested?
'iDOVE2' is being tested to prevent peer violence and depression among at-risk youth. It includes an initial brief session in the emergency department followed by ongoing automated text messages designed to support mental health over time.See study design
What are the potential side effects?
Since 'iDOVE2' involves non-medical interventions like educational sessions and text messaging, traditional side effects associated with medications are not expected. However, there may be emotional or psychological impacts from discussing sensitive topics.

iDOVE2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months before enrollment and 12 months after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months before enrollment and 12 months after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Center for Epidemiologic Studies Depression Scale Revised (CESD-R)
Conflict Tactics Scale-2, physical subset (CTS-2)
Secondary outcome measures
Change in ED Visits for Assault-Related Injury
Conflict in Adolescent Dating Relationships Inventory, physical subset (CADRI)
Illinois Bully Scale (IBS)
+1 more
Other outcome measures
Bosworth Violence Self-Efficacy Scale
Emotional Regulation Questionnaire for Children and Adolescents (ERQ-CA)
Self-Efficacy Questionnaire for Children (SEQ-C)

iDOVE2 Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: No Brief ED Intervention (BI), + TextExperimental Treatment1 Intervention
Participants receive the Text Message Intervention component only (8 weeks of an automated, tailored, two-way text-message curriculum started after the ED visit, which reinforces cognitive reappraisal, emotional regulation, and self-efficacy skills). Participants receive a brochure containing online and community resources for violence and depression prevention instead of the Brief ED Intervention component.
Group II: + Brief ED Intervention (BI), no TextExperimental Treatment1 Intervention
Participants receive the Brief ED Intervention component only (which is a 20-minute Motivational Interviewing- and Cognitive Behavioral Therapy-based in-Emergency Department session delivered by a bachelors'-level Research Assistant).
Group III: + Brief ED Intervention (BI), + TextExperimental Treatment2 Interventions
Participants receive both the Brief ED Intervention component (a 20-minute Motivational Interviewing- and Cognitive Behavioral Therapy-based in-Emergency Department session delivered by a bachelors'-level Research Assistant) and the Text Message Intervention component (8 weeks of an automated, tailored, two-way text-message curriculum started after the ED visit, which reinforces cognitive reappraisal, emotional regulation, and self-efficacy skills).
Group IV: No Brief ED Intervention (BI), no TextActive Control1 Intervention
Participants receive neither the Brief ED Intervention component, nor the Text Message Intervention component. Participants receive a brochure containing online and community resources for violence and depression prevention, instead of the Brief ED Intervention component.

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
260 Previous Clinical Trials
70,934 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,956 Previous Clinical Trials
2,671,420 Total Patients Enrolled
Megan L Ranney, MD MPHPrincipal InvestigatorYale School of Public Health
1 Previous Clinical Trials
77 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age of seventy preclude someone from participating in this experiment?

"Patients aged between 13 and 17 are able to partake in this medical trial, with the criteria for eligibility being met. Additionally, there exist 196 clinical trials appropriate for minors and 971 that involve seniors over 65 years old."

Answered by AI

What goals have been established to evaluate the success of this research project?

"This research experiment, which will be assessed at enrolment and two, four, and eight months post-enrolment points in time is looking to quantify Conflict Tactics Scale-2 physical subset (CTS-2). Secondary metrics include the Illinois Bully Scale (IBS), Student School Survey changes from initial enrollment with regards to other forms of peer violence (bullying) as well as Conflict in Adolescent Dating Relationships Inventory Physical Subset(CADRI) progress since implementation."

Answered by AI

Are there opportunities available to join this scientific experiment?

"This clinical research is recruiting 800 minors, aged 13-17, who are suffering from melancholia. To be eligible for the trial they must fulfil these prerequisites: fluency in English language, physical violence within past year (using a modified The Revised Conflict Tactics Scales (CTS-2) score ≥1), mild to moderate depressive symptoms during last 2 weeks (Patient Health Questionnaire (PHQ-9) score 5 -19), accompanied by parent/guardian able to provide consent and have access to cell phone with text messaging capability."

Answered by AI

How many participants are enrolled in this research endeavor?

"Indeed, the clinicaltrials.gov website confirms that this research project is currently open for recruitment. It was first made available on August 1st 2018 and last modified on December 21 2020; 800 participants are being recruited from one site."

Answered by AI

Are there still patient slots available for this investigation?

"As indicated by clinicaltrials.gov, the recruitment process for this clinical trial is underway and has been active since its initial posting on August 1st 2018. The details of the study were last revised in December 2020."

Answered by AI
~103 spots leftby Feb 2025